Cart
sales@molnova.com
Fibrin
CAS No. 9001-31-4
Fibrin( —— )
Catalog No. M24924 CAS No. 9001-31-4
Fibrin is the major component of the blood clot and is used for coagulation.Fibrin, isolated from bovine blood, is an insoluble protein produced in response to bleeding.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 39 | In Stock |
|
| 50MG | 61 | In Stock |
|
| 100MG | 90 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFibrin
-
NoteResearch use only, not for human use.
-
Brief DescriptionFibrin is the major component of the blood clot and is used for coagulation.Fibrin, isolated from bovine blood, is an insoluble protein produced in response to bleeding.
-
DescriptionFibrin is the major component of the blood clot and is used for coagulation.Fibrin, isolated from bovine blood, is an insoluble protein produced in response to bleeding.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number9001-31-4
-
Formula Weight145.16
-
Molecular FormulaC5H11N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:< 1 mg/mL?(insoluble or slightly soluble)
-
SMILESCNC(=O)CNC(=O)CN
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Paulson CN, et al. The anti-parasitic agent suramin and several of its analogues are inhibitors of the DNA bindingprotein Mcm10. Open Biol. 2019 Aug 30;9(8):190117.
molnova catalog
related products
-
Ganoderic acid GS-2
Ganoderic acid GS-2 can inhibit the activity of human immunodeficiency virus -1 protease.
-
BI 1467335
BI 1467335 (PXS-4728A,?PXS-4728) is a potent, selective, orally active SSAO/VAP-1 (AOC3) inhibitor with IC50 of 5 nM.
-
Salvianan
Salviane exhibits the most potent cytotoxicity with a CD50 range of 30.4-39.5 microM against HeLa (cervical epitheloid carcinoma), HepG2 (hepatocellular carcinoma), and OVCAR-3 (ovarian adenocarcinoma) cell lines in a dose-dependent manner.
